The Use of Chemoprevention Following Breast Biopsy in Women at High Risk for Developing Breast Cancer
Abstract
Context: Breast cancer chemoprevention is recognized as an effective strategy for risk reduction in women at high risk for the future development of breast cancer. Women with a history of breast biopsy revealing atypical hyperplasia or lobular carcinoma in situ are at particularly high risk for developing breast cancer. The rates of chemoprevention counseling and prescribing in this population are unknown. Objective: To determine the practice patterns of general surgeons who perform breast biopsies with regard to breast cancer chemoprevention counseling and prescribing. Design: Cross-sectional descriptive study based on the results of a selfadministered questionnaire mailed to general surgeons. Participants: General surgeons living in and licensed to practice in North Carolina. In the data analysis, we will exclude those respondents whose practice does not include breast care. Main Outcome Measures: Rates of breast cancer chemoprevention counseling and prescribing. Description of surgeon and practice characteristics related to counseling and prescribing. Description of referral patterns for chemoprevention counseling and prescribing. Results: Pending at this time. Once data collection is complete, we may anticipate the following results: I. Surgeons are not discussing chemoprevention with high risk patients OR 2. Surgeons discuss or recommend chemoprevention but do not prescribe it OR 3. Surgeons discuss and prescribe chemoprevention Conclusions: If surgeons are not…
How strong is the evidence?
Evidence Hub reads this as a cross-sectional, done in people. Its evidence level is 4 of 5 (Low · observational). Observational designs can show an association but not prove cause.
Read the paper
Related studies
- Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults
- Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME
- THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
- The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
- Mannich bases in medicinal chemistry and drug design
- Melastoma malabathricum(L.) Smith Ethnomedicinal Uses, Chemical Constituents, and Pharmacological Properties: A Review
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.